Viewing Study NCT01443351


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-23 @ 4:54 AM
Study NCT ID: NCT01443351
Status: WITHDRAWN
Last Update Posted: 2019-09-11
First Post: 2011-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)
Sponsor: Zealand University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Idiopathic Thrombocytopenic Purpura View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ITP View
None romiplostim View
None eltrombopag View
None bone marrow fibrosis View
None long-term safety View